01 What is BPC-157?
In plain English.
BPC-157 is a lab-made chain of 15 [amino acids](/glossary "Amino acid: The building blocks of proteins. A peptide is a short chain of them linked together."), a small peptide. It's based on a fragment of a protective protein that naturally occurs in the human digestive tract. Researchers became interested in it because, in animals, it appeared to speed up the repair of injured tissue like tendons, ligaments, gut lining and muscle.
It's most commonly discussed in fitness and recovery circles as an injury-healing aid. Important to be clear: almost everything known about it comes from rats and mice, not from proper human trials.
02 How it works
The simple version, then the science.
The leading idea is that BPC-157 helps the body build new blood vessels at an injury site (angiogenesis). More blood flow means more oxygen and nutrients reaching damaged tissue, which could in theory help it repair faster.
Go deeper · the proposed mechanism
In animal models, BPC-157 has been reported to upregulate the VEGFR2 signalling pathway, modulate nitric oxide synthesis (eNOS and iNOS), and activate the FAK-paxillin pathway involved in cell migration. These mechanisms come from preclinical work and have not been confirmed in controlled human studies, so read them as hypotheses rather than established pharmacology.
03 What it's used for
Each use graded by how strong the evidence actually is.
- PreclinicalTendon & ligament healingStrong, repeated results in rodents. No published controlled human trials confirming the effect.
- PreclinicalGut & ulcer protectionThe most-studied area in animals; the peptide was first characterised for gastric protection.
- AnecdotalJoint & muscle recovery in athletesPopular real-world use, but supported only by self-reports.
- AnecdotalReducing inflammationClaimed widely; human data is absent.
04 What the evidence says
The animal literature is genuinely substantial and fairly consistent, multiple rodent studies point to accelerated tissue repair. The problem is the gap between a mouse and a person: promising animal results frequently fail to translate to humans, and BPC-157 has not yet been through the controlled human trials that would settle the question. A first-in-human trial (RECOVER) began recently. Much online enthusiasm also originates from sellers, so treat strong claims with caution. In short: an interesting preclinical signal, but no proven human benefit and unknown long-term safety.
05 Dosing & administration
Reported in the literature, information not advice.
In research and anecdotal reports, BPC-157 is described as given by subcutaneous injection, with oral forms also sold. Reported amounts vary widely. Because there are no approved human protocols, no safe or effective dose has been established, and a qualified clinician should be consulted before considering any peptide.
06 Side effects & safety
Because there are no large human studies, the side-effect profile in people is essentially unknown. Animal studies report relatively low toxicity, but that does not establish human safety, purity, or long-term risk. Products sold online are unregulated, so contamination and mislabelling are real concerns. People who are pregnant, breastfeeding, have cancer, or take other medicines should be especially cautious.
07 Where to buy
Sold "research use only", so verification matters more than price.
08 Legal & regulatory status
- UKNot licensed as a medicine. Sold only as a "research chemical", not for human use.
- USNot FDA-approved. The FDA has flagged it for restriction in compounding.
- SportProhibited at all times by WADA as a non-approved substance.
09 Clinical studies & research
Primary sources. Read the science yourself.